U82.1
Conditions
Interventions
Group 1: Prospective study part: Observation of course of disease and therapy as well as therapy outcome in adult patients with multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB) in
Sponsors
CAPNETZ STIFTUNG
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) Written consent to participate in the study after language-based explanation of the study objectives and procedures 2) MDR/RR therapy in one of the participating study centers
Exclusion criteria
Exclusion criteria: 1) Restrictions due to which, in the opinion of the study physicians, it is not possible to give informed consent to participate in the study 2) Restrictions due to which, in the opinion of the study physicians, it is not possible to understand and fulfill the study requirements. 3) Concurrent participation in an interventional study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment failure y/n is recorded after the therapy outcome is available, at the latest after the longest possible duration of therapy (18 months (+/- 4 weeks), either directly at the participating study center or by contacting physicians providing further treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) MDR-TB treatment regimen 2) Healthcare reality and structure of MDR-TB (e.g. treatment duration, treatment structure, counseling and support services) 3) Guideline adherence 1) Recording after the treatment outcome is available (see primary endpoint) 2 and 3) Recording as part of follow-up surveys on the course of the disease and treatment at discharge and subsequent follow-up observations | — |
Countries
Germany
Contacts
Public ContactFrank Eberhardt
CAPNETZ STIFTUNG
Outcome results
None listed